Status:

COMPLETED

Caregiver-Assisted Oral Fluid-based HIV Screening in Children: Uganda

Lead Sponsor:

Catholic Relief Services

Collaborating Sponsors:

Centers for Disease Control and Prevention

Conditions:

HIV Testing

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to evaluate the acceptability, feasibility and effectiveness of a caregiver-assisted oral fluid-based HIV test to screen children for HIV. The results of this study are in...

Detailed Description

Rationale: Globally, there are 1.8 million children living with HIV (CLHIV), however, despite great progress over the past 15 years, only 52% are receiving antiretroviral therapy (ART), leaving approx...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Index parent/caregivers:
  • HIV-positive diagnosis
  • 18 years old or older
  • Emancipated minors (15-17 years of age) with eligible children
  • Inclusion Criteria for eligible children:
  • Biological children (of an index parent/caregiver) 18 months - 14 years of age with an unknown HIV status
  • Non-biological children living in the same household as the index parent/caregivers where the child has a history of HIV exposure (where the mother is HIV-positive, of unknown status, unavailable for testing, or who is deceased)
  • Biological children (of an index parent/caregiver) 18 months - 14 years of age, as well as non-biological children living in the same household as the index parent/caregiver where the child has a history of HIV exposure (where the mother is HIV-positive, of unknown status, unavailable for testing, or who is deceased), with a known previous HIV-negative status completed less than three months following the cessation of breastfeeding and whose parent/caregiver states that there is reason to suspect a new exposure
  • Inclusion criteria for participation in survey after completion of care giver-assisted oral fluid-based HIV screening:
  • • Adult index parents who complete the oral-based HIV screening with at least one eligible child, regardless of screening result.
  • Exclusion Criteria for Index parent/caregivers:
  • Adults answering "yes" to any of the first three intimate partner violence (IPV) risk assessment questions
  • Adults answering "yes", "maybe" or I don't know" to the fourth IPV question
  • Those unable to provide independent informed consent due to mental disability or other limitations (as deemed by study staff)
  • Exclusion Criteria for eligible children:
  • Children \<18 months of age
  • Children 18 months - 14 years of age with a known HIV-positive status
  • Biological children (of an index parent/caregiver) 18 months - 14 years of age where the child has a history of HIV exposure (where the mother is HIV-positive, of unknown status, unavailable for testing, or who is deceased), with previous known HIV-negative status completed less than three months following the cessation of breastfeeding and whose parent/caregiver states that they have no reason to suspect a new exposure
  • Non-biological children living in the same household as the index parent/caregiver age where the child has a history of HIV exposure (where the mother is HIV-positive, of unknown status, unavailable for testing, or who is deceased), with previous known HIV-negative status completed less than three months following the cessation of breastfeeding and whose parent/caregiver states that they have no reason to suspect a new exposure
  • Children still breastfeeding
  • Children with cessation of breastfeeding \< 3 months
  • Exclusion criteria for participation in survey after completion of oral-based HIV screening:
  • • Adult index parent/caregivers who do not complete the oral-based HIV screening with at least one eligible child

Exclusion

    Key Trial Info

    Start Date :

    April 19 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    October 8 2021

    Estimated Enrollment :

    4865 Patients enrolled

    Trial Details

    Trial ID

    NCT04774666

    Start Date

    April 19 2021

    End Date

    October 8 2021

    Last Update

    March 11 2022

    Active Locations (32)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 8 (32 locations)

    1

    Bugiri Hospital

    Bugiri, Bugiri District, Uganda

    2

    Nankoma HC IV

    Bugiri, Bugiri District, Uganda

    3

    Kabuyanda HC IV

    Kabuyanda, Isingiro District, Uganda

    4

    Rwekubo HC IV

    Kahirimbi, Isingiro District, Uganda